Neuren Pharmaceuticals (ASX:NEU): Another exciting chapter is yet to come with NNZ-2591
Neuren Pharmaceuticals (ASX:NEU) is an ASX biotech company that has had a stellar past few years, but it is now…
Read More
What the Tariff Pause Means for Apple: Can the Stock Continue Its Recovery?
After shedding nearly 30% of their value between December 24 last year and April 8 this year, shares in Apple…
Read More
CSL (ASX:CSL): Its promised double-digit earnings growth for the rest of the 2020s, but will Trump’s tariffs shatter the dream?
CSL has been hit more than most other stocks due to Trump tariffs. While many companies being sold off merely…
Read More